Novel nanostructure-coupled biosensor platform for one-step high-throughput quantification of serum neutralizing antibody after COVID-19 vaccination.

Novel nanostructure-coupled biosensor platform for one-step high-throughput quantification of serum neutralizing antibody after COVID-19 vaccination.
复制标题

新型纳米结构耦合生物传感器平台,用于对 COVID-19 疫苗接种后血清中和抗体进行一步高通量定量

DOI:
10.1016/j.bios.2021.113868
复制
发表时间:
2022-03-01
影响因子:
12.6
通讯作者:
Liu GL
Liu GL
中科院分区:
工程技术1区
文献类型:
--
作者:
Huang L;Li Y;Luo C;Chen Y;Touil N;Annaz HE;Zeng S;Dang T;Liang J;Hu W;Xu H;Tu J;Wang L;Shen Y;Liu GL

文献摘要

参考文献

被引文献

相似文献

COVID-19疫苗效率取决于对严重急性呼吸综合征2(SARS-COV-2)峰值尖峰蛋白的中和抗体(NAS)的血清水平(NAS)。和评估开发了一种新型的纳米质免疫吸附测定(Nanopisa)平台,用于在临床血清样品中快速量化SARS-COV-2 NAS NAS,以高通量评估COVID-19,可通过使用Nanoporov hollow cov的nanopiss-limimect-limimect-limimect-limimect-limimect-limimect-limimect-limimect-limimect-limit ottercov syct-limim cot ottercov syct sans sars sars sars sars sars sars。一步临床标本中SARS-COV-2 NA检测的纳米异常可以与金标准的Seronetralization检验和替代病毒中和替代酶联的免疫吸收测定法相当,这是一种快速和高度介绍的NAanopisa vercative-naopisa vercation-naopisa coviens-naopisa corvientive-naopisa corvientive-naopisa corvientived-naopisa coviens-naopisa coviensive-5
COVID-19 vaccination efficacy depends on serum levels of the neutralizing antibodies (NAs) specific to the receptor-binding domain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein. Therefore, a high-throughput rapid assay capable of measuring the total SARS-CoV-2 NA level is urgently needed for COVID-19 serodiagnosis, convalescent plasma therapy, vaccine development, and assessment. Here, we developed a novel nanoplasmonic immunosorbent assay (NanoPISA) platform for one-step rapid quantification of SARS-CoV-2 NAs in clinical serum samples for high-throughput evaluation of COVID-19 vaccine effectiveness. The NanoPISA platform enhanced by the use of nanoporous hollow gold nanoparticle coupling was able to detect SARS-CoV-2 NAs with a limit of detection of 0.2 pM within 15 min without washing steps. The one-step NanoPISA for SARS-CoV-2 NA detection in clinical specimens yielded good results, comparable with those obtained in the gold-standard seroneutralization test and the surrogate virus-neutralizing enzyme-linked immunosorbent assay. Collectively, the one-step NanoPISA might be a rapid and high-throughput NA-quantification platform for evaluating the effectiveness of COVID-19 vaccines.
DOI: 10.1021/acsomega.0c01554
发表时间: 2020-06-02
期刊: ACS OMEGA
影响因子: 4.1
作者:
Huang, Chao;Wen, Tian;Jiao, Yong-Jun
通讯作者: Jiao, Yong-Jun
DOI: 10.1126/science.abb5793
发表时间: 2020-05-22
期刊: SCIENCE
影响因子: 56.9
作者:
Kissler, Stephen M.;Tedijanto, Christine;Lipsitch, Marc
通讯作者: Lipsitch, Marc
通过纳米等离子体彩色成像检测人唾液中的 C 反应蛋白
DOI: 10.1166/jbn.2019.2769
发表时间: 2019-08-01
影响因子: 2.9
作者:
Hu, Wenjun;Dang, Tang;Liu, Gang Logan
通讯作者: Liu, Gang Logan
DOI: 10.1016/j.jaut.2021.102715
发表时间: 2021-11
影响因子: 12.8
作者:
Kannan SR;Spratt AN;Cohen AR;Naqvi SH;Chand HS;Quinn TP;Lorson CL;Byrareddy SN;Singh K
通讯作者: Singh K
DOI: 10.1016/j.bios.2019.02.047
发表时间: 2019-05-01
影响因子: 12.6
作者:
Cetin, Arif E.;Topkaya, Seda Nur
通讯作者: Topkaya, Seda Nur